NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/12/2024
Voltar para busca
Dado oficial do USPTO
CELLUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
24/12/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
30/07/2021
Data de registro
24/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/12/2024
Última transação
24/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
03
Localização do titular
Daegu, KR
Examinador
MORRIS, ALINA
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "cellus" in stylized font and a total of ten dots below. The dots are arranged in two separate lines, four dots being on the first line below the letters "us" and six dots on the second line further below.
Titulares e representantes
Titulares
cellus Inc.
Representantes
Jihun Kim Bridgeway IP Law Group, PLLC
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Laboratory services relating to the production of monoclonal antibodies; Toxicity analysis; Research and development of vaccines and medicines; Scientific research in the fields of biomedicine; Medical research in the field of crude drugs; Research and testing services in the fields of bacteriology and virology; Development of cell therapy products; Drug discovery services; Laboratory equipment product research; Scientific laboratory services for laboratory use; Scientific research for medical purposes in the field of cancerous diseases; Inspection of pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical products evaluation; Clinical testing of medicines; Animal semen testing services for research purposes; Medical laboratory services; Research and development of medical apparatus and instruments for others; Scientific research services for medical purposes; Research and development of peptide for medical purposes; Research and development of technology for medicinal chemical manufacturing; Research and development of medical equipment; Development of medical devices; Medical research laboratory services for predicting disease; Providing information on the testinginspectionresearch of medical products; Medical and pharmacological research services; Engineer servicesengineering in the field of medical device and software technology; Analysis of biopsy results for medical research purposes; Analysis of blood test results for medical research purposes; Medical research services; Stem cell research services; Blood analysis services
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/10/2024
PUBO
PUBLISHED FOR OPPOSITION
22/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/10/2024
OTHE
CASE RETURNED TO EXAMINATION
10/09/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/09/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
09/09/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/09/2024
APET
ASSIGNED TO PETITION STAFF
05/09/2024
EX4G
SOU EXTENSION 4 GRANTED
17/08/2024
EXT4
SOU EXTENSION 4 FILED
17/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/08/2024
EEXT
SOU TEAS EXTENSION RECEIVED
16/08/2024
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
05/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/01/2024
EX3G
SOU EXTENSION 3 GRANTED
22/01/2024
EXT3
SOU EXTENSION 3 FILED
22/01/2024
EEXT
SOU TEAS EXTENSION RECEIVED
22/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/07/2023
EX2G
SOU EXTENSION 2 GRANTED
19/07/2023
EXT2
SOU EXTENSION 2 FILED
19/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
19/07/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/01/2023
EX1G
SOU EXTENSION 1 GRANTED
10/01/2023
EXT1
SOU EXTENSION 1 FILED
10/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/09/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/09/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
28/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/09/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/06/2022
PUBO
PUBLISHED FOR OPPOSITION
21/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2022
GNRT
NON-FINAL ACTION E-MAILED
04/05/2022
CNRT
NON-FINAL ACTION WRITTEN
04/05/2022
DOCK
ASSIGNED TO EXAMINER
27/04/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
28/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/09/2021
NWAP
NEW APPLICATION ENTERED
03/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.